Literature DB >> 15336690

Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings.

John G Quinlan1, Harvey S Hahn, Brenda L Wong, John N Lorenz, Alexandra S Wenisch, Linda S Levin.   

Abstract

Heart failure is a major cause of death in boys with Duchenne muscular dystrophy. In order to determine if the cardiac function of the mdx mouse is similarly disturbed, we performed murine echocardiograms and left heart catheterization studies, along with morphometric analysis of cardiac fibrosis. Serial echocardiograms in mdx mice revealed the evolution from normal cardiac function in young mice to a dilated cardiomyopathy in adult mice. Very old mdx mice exhibited a widespread but patchy increase in ventricular wall fibrosis. These results show that the mdx cardiac function is more impaired than was previously thought and shares important clinical features with the cardiomyopathy of Duchenne muscular dystrophy.

Entities:  

Mesh:

Year:  2004        PMID: 15336690     DOI: 10.1016/j.nmd.2004.04.007

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  127 in total

1.  Patchy or homogenous myocardial fibrosis in Becker muscular dystrophy? Comments on Süselbeck et al., Z Kardiol 94:465-468/2005.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Clin Res Cardiol       Date:  2006-04       Impact factor: 5.460

2.  Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy.

Authors:  Brian Bostick; Yongping Yue; Dongsheng Duan
Journal:  Muscle Nerve       Date:  2010-10       Impact factor: 3.217

3.  AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice.

Authors:  Brian Bostick; Jin-Hong Shin; Yongping Yue; Dongsheng Duan
Journal:  Mol Ther       Date:  2011-08-02       Impact factor: 11.454

4.  Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.

Authors:  Saurabh Dahiya; Srikanth Givvimani; Shephali Bhatnagar; Natia Qipshidze; Suresh C Tyagi; Ashok Kumar
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

5.  Pathways of abnormal stress-induced Ca2+ influx into dystrophic mdx cardiomyocytes.

Authors:  M Fanchaouy; E Polakova; C Jung; J Ogrodnik; N Shirokova; E Niggli
Journal:  Cell Calcium       Date:  2009-07-14       Impact factor: 6.817

6.  Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.

Authors:  Tatyana A Meyers; DeWayne Townsend
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

7.  Calcium-binding proteins in skeletal muscles of the mdx mice: potential role in the pathogenesis of Duchenne muscular dystrophy.

Authors:  Adriana Pertille; Candida Luiza Tonizza de Carvalho; Cintia Yuri Matsumura; Humberto Santo Neto; Maria Julia Marques
Journal:  Int J Exp Pathol       Date:  2009-12-03       Impact factor: 1.925

8.  Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice.

Authors:  Brian Bostick; Yongping Yue; Yi Lai; Chun Long; Dejia Li; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2008-08       Impact factor: 5.695

Review 9.  Vinculin and talin: focus on the myocardium.

Authors:  Alice Zemljic-Harpf; Ana Maria Manso; Robert S Ross
Journal:  J Investig Med       Date:  2009-12       Impact factor: 2.895

10.  Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.

Authors:  Sean M Lang; Tarek Alsaied; Philip R Khoury; Thomas D Ryan; Michael D Taylor
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-20       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.